The safety and efficacy of propofol containing EDTA: A randomised clinical trial programme focusing on cation and trace metal homeostasis in critically III patients

Intensive Care Medicine, Supplement

Volumn 26, Issue 4, 2000, Pages

  Zaloga, G P ^a   Teres, D ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CATION; EDETIC ACID; MAGNESIUM; METAL CHELATE; PROPOFOL; TRACE METAL; ZINC;

CHELATION; CLINICAL TRIAL; CRITICAL ILLNESS; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HOMEOSTASIS; HUMAN; INFECTION; INTENSIVE CARE; MAGNESIUM BLOOD LEVEL; RANDOMIZATION; ZINC BLOOD LEVEL;

ANESTHETICS, INTRAVENOUS; CATIONS; CHELATING AGENTS; CONSUMER PRODUCT SAFETY; CRITICAL ILLNESS; EDETIC ACID; HOMEOSTASIS; HUMANS; PRESERVATIVES, PHARMACEUTICAL; PROPOFOL; TRACE ELEMENTS;

EID: 0034519768     PISSN: 09351701     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (5)

1. Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation
2. Behavior of heavy metals in human urine and blood following calcium disodium ethylenediamine tetraacetate injection: Observations in metal workers
3. Metal excretion and magnesium retention in patients with intermittent claudication treated with intravenous disodium EDTA
4. Randomized trials or observational tribulations?
5. Diprivan: A change in formulation